Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Equity Ratio: 2023-2025

Historic Equity Ratio for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to 0.92.

  • Tonix Pharmaceuticals Holding's Equity Ratio rose 17.20% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year increase of 17.20%. This contributed to the annual value of 0.86 for FY2024, which is 25.40% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Equity Ratio stood at 0.92, which was up 2.11% from 0.90 recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Equity Ratio peaked at 0.94 during Q1 2025, and registered a low of 0.60 during Q2 2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Equity Ratio averaged around 0.83, with its median value being 0.87 (2023).
  • In the last 5 years, Tonix Pharmaceuticals Holding's Equity Ratio tumbled by 31.90% in 2024 and then surged by 49.73% in 2025.
  • Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Equity Ratio stood at 0.68 in 2023, then rose by 25.40% to 0.86 in 2024, then grew by 17.20% to 0.92 in 2025.
  • Its last three reported values are 0.92 in Q3 2025, 0.90 for Q2 2025, and 0.94 during Q1 2025.